The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α‐synuclein
Abstract
Recently, α‐synuclein was shown to be a structural component of the filaments in Lewy bodies (LBs) of Parkinson's disease (PD), dementia with LBs (DLB) as well as the LB variant of Alzheimer's disease, and this suggests that α‐synuclein could play a mechanistic role in the pathogenesis of these disorders. To determine whether α‐synuclein is a building block of inclusions in other neurodegenerative movement disorders, we examined brains from patients with multiple system atrophy (MSA) and detected α‐synuclein, but not β‐ or γ‐synuclein, in glial cytoplasmic inclusions (GCIs) throughout the MSA brain. In MSA white matter, α‐synuclein–positive GCIs were restricted to oligodendrocytes, and α‐synuclein accumulated selectively in MSA white matter with α‐synuclein–positive GCIs. Taken together with evidence that LBs contain insoluble α‐synuclein, our data suggest that a reduction in the solubility of α‐synuclein may induce this protein to form filaments that aggregate into cytoplasmic inclusions, which contribute to the dysfunction or death of glial cells as well as neurons in neurodegenerative disorders with different phenotypes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MSA is a synucleinopathy, however, unlike PD and dementia with Lewy bodies, in which α-syn accumulates and aggregates in neurons, MSA is characterized neuropathologically by α-syn-positive glial cytoplasmic inclusions (GCIs) in oligodendroglia [1, 42, 54, 58, 59].”
From Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates (2017) · cites this paper as [54]
In the citing paper
“The pathological hallmark of MSA is the abnormal accumulation of α-syn in the cytoplasm of oligodendrocytes, named glial cytoplasmic inclusions (GCIs).271–275”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [272]
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Self-citationMutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 2,868
Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal
Maroteaux, L., Campanelli, J., & Scheller, R. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-08-02804.1988 · Cited by 1,646
(1998) · Europe PMC (PubMed Central) · Cited by 1,594
Self-citationMolecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.
Uéda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D. A., Kondo, J. D. M., Ihara, Y., & Saitoh, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11282 · Cited by 1,502
Iwai, A., Masliah, E., Yoshimoto, M., Ge, N., Flanagan, L., Rohan de Silva, H. A., Kittel, A., & Saitoh, T. (1995) · Neuron · doi:10.1016/0896-6273(95)90302-x · Cited by 1,316
Identification of two distinct synucleins from human brain
Jakes, R., Spillantini, M. G., & Goedert, M. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00395-5 · Cited by 1,080
Papp, M. I., Kahn, J. E., & Lantos, P. L. (1989) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(89)90219-0 · Cited by 991
Cited by
Sorted by citations
Items 601–681 of 681
Neuropathology of Parkinson's disease
Dickson, D. W. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544873.040 · Cited by 1
Apetri, M. M. (2006) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 1
Chiara, S., Bon, C., Cecco, E. D., Marta, C., Narkiewicz, J., Pietro, P., Perissinotto, F., Claudio, S., Francesca, P., Giuseppe, L., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.13.464204 · Cited by 1
“In MSA, the typical α-syncontaining glial cytoplasmic inclusions are restricted to oligodendrocytes [46].”
BackgroundBureau, S. C. (2022) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2022-14889 · Cited by 1
Heras‐Garvin, A., & Stefanova, N. (2021) · Springer eBooks · doi:10.1007/978-3-030-71519-9_228-1 · Cited by 1
Structure of a novel α-synuclein filament fold from multiple system atrophyPreprint
Yan, N., Candido, F., Tse, E., de Melo, A. A., Prusiner, S. B., Mordes, D. A., Southworth, D. R., Paras, N. A., & Merz, G. E. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.01.601365 · Cited by 1
Purification of Lewy Bodies and Identification of α-Synuclein as a Major Component of Lewy Bodies
Iwatsubo, T., Baba, M., Lee, V. M., & Trojanowski, J. Q. (2000) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-662-04056-0_2 · Cited by 1
Self-citationDuda, J. E., Lee, V. M. ‐., & Trojanowski, J. Q. (2001) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8225-5_15 · Cited by 1
Self-citationChapter 3 Multiple System Atrophy
Geser, F., Globas, C., Schöls, L. J., & Wenning, G. K. (2007) · Blue books of neurology · doi:10.1016/s1877-184x(09)70077-2
Klockgether, T. (2005) · Elsevier eBooks · doi:10.1016/b978-343723390-6.50053-x
Molecular Biology of Lewy Body Formation
Spillantini, M. G., & Tofaris, G. K. (2002) · Advances in behavioral biology · doi:10.1007/978-0-306-47593-1_83
Molecular Biology of α-Synuclein
Rieß, O., Krüger, R., Kobayashi, H., Holzmann, C., Hattori, N., & Mizuno, Y. (2002) · Advances in behavioral biology · doi:10.1007/978-0-306-47593-1_85
Regional lysosomal malfunction underlies the selectivity of alpha-synuclein neurodegeneration
Malkus, K. A. (2011) · Scholarly Commons (University of Pennsylvania)
Hochegger, K., & Ar, R. (2007) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Stemberger, S., & Wenning, G. K. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511977749.002
Expression of α- and β-synucleins in cultured astrocytes and the effects of inflammatory cytokines
Tanji, K., Mori, F., Imaizumi, T., Yoshida, H., Takahashi, H., Satoh, K., & Wakabayashi, K. (2003) · International Congress Series · doi:10.1016/s0531-5131(03)00118-3
Mori, F., Tanji, K., Yoshimoto, M., Takahashi, H., & Wakabayashi, K. (2003) · International Congress Series · doi:10.1016/s0531-5131(03)00106-7
Familial Variants of Parkinson’s Disease
Gwinn, K. A., Hanson, M., Wszołek, Z. K., Adam, A., Singleton, A., Adler, C. H., Caviness, J. N., Bower, J. H., Hickey, S., Chen, J. Y., et al. (2002) · Advances in behavioral biology · doi:10.1007/978-0-306-47593-1_47
Behavioural analysis of transgenic mice overexpressing gamma-synuclein
Salem, H. (2011) · ORCA Online Research @Cardiff (Cardiff University)
Diseases: New Concepts of Pathogenesis and Their Therapeutic Implications
Skovronsky, D., Lee, V. M. ‐., & Trojanowski, J. Q. (2006)
Self-citationAhlstrand, K., & Sullivan, P. M. (2010) · Eukaryon
Savolainen, M. H. (2015) · Työväentutkimus Vuosikirja
Extracellular vesicle release of α-Synuclein is mediated by SUMOylation
Kunadt, M. (2015) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5371
Poggel, C. (2000) · Kölner Universitäts PublikationsServer (Universität zu Köln)
Protein Aggregation and Neurodegeneration: Tauopathies and Synucleinopathies
Goedert, M. (2017) · Neurodegeneration · doi:10.1002/9781118661895.ch2
Pathogenic mechanisms in multiple system atrophy: a study of oligodendroglial pathology
Asi, Y. T. (2014) · UCL Discovery (University College London)
Analysis of copy number variation and disease mechanisms underlying Parkinson’s disease
van der Merwe, C. (2016) · SUNScholar (Stellenbosch University)
Kovács, G. G., Leisser, I., Budka, H., Wagner, U., Lachmann, O. I., Perret-Liaudet, D. A., Dumont, B., Perret‐Liaudet, A., Pikkarainen, M., Alafuzoff, I. I., et al. (2012)
Alteraciones neuropsicológicas en las α-sinucleinopatías
Rivera, M. M., Menéndez‐González, M., & Muñiz, A. J. L. (2011) · Archivos de Medicina
Miller‐Patterson, C., Krobot, K. E., Burton, E. A., & Smith, L. J. (2020) · Springer eBooks · doi:10.1007/978-3-030-28852-5_13
Alpha-synuclein as a regulator of synaptic signalling
Pelkonen, A. (2013) · UEF eRepo (University of Eastern Finland)
Shoaei, Z. S. (2018) · TSpace (University of Toronto)
Can a Type-2 Diabetes Mellitus drug be hope for Multiple System Atrophy?
Demir, Y. (2020) · Advances in Clinical Neuroscience & Rehabilitation · doi:10.47795/rlyy2780
Foubert‐Samier, A., Tison, F., & Meissner, W. G. (2015) · EMC - Neurologia · doi:10.1016/s1634-7072(15)70513-1
Fasano, A. A., & Breen, D. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733203098.793545981
Faculty Opinions recommendation of Cryo-EM structure of alpha-synuclein fibrils.
Scheres, S. H. W. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733570511.793550310
Liang, T. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108942751.018
Role of fatty acid-binding protein 7 and novel therapeutic approach in synucleinopathies
Cheng, A., & Fukunaga, K. (2022) · Folia Pharmacologica Japonica · doi:10.1254/fpj.22056
IFNγ drives neuroinflammation and demyelination in a mouse model of multiple system atrophyPreprint
Gallups, N. J., Childers, G. M., Webster, J. M., Zane, A., Yang, Y.-T., Mudium, N., Manfredsson, F., Kordower, J., & Harms, A. (2022) · bioRxiv · doi:10.1101/2022.11.22.517543
Feasibility and considerations of epsin2 as a candidate target for multiple system atrophy treatment
Cheng, A., Cai, B., Fukunaga, K., Sasaki, T., & Lakkaraju, A. (2023) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2023.2277227
“These αSyn aggregates were insoluble in high salt buffer but could be extracted using a buffer containing SDS. Similarly, αSyn found in GCI fractions from the brains of MSA patients demonstrated insolubility in high salt buffer [10].”
BackgroundTsuji, S., Nakahara, Y., Mitsui, J., Date, H., Porto, K. J. L., Hyashi, Y., Yamashita, A., Kusakabe, Y., Matsukawa, T., Ishiura, H., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3461290/v1
Self-citationVidal-Martínez, G., Lou, H., & Perez, R. G. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1005448
Skin Biomarkers of Neurodegenerative Diseases
Reilly-Jankowiak, L., Bargar, C., Bunn, D., & Chen, S. G. (2025) · Springer eBooks · doi:10.1007/978-3-031-66513-4_6
Marqueurs biologiques des maladies neurodégénératives
Vrillon, A., Aveneau, C., & Paquet, C. (2025) · Encyclopédie médico-chirurgicale. Neurologie · doi:10.1016/s0246-0378(25)48607-2
A Case of Multiple System Atrophy Associated with a Homozygous Coq2 Mutation (N228s, C.683a>G)Preprint
Monte, D. D., Ermanis, G., Belgrado, E., Bernardini, A., Lettieri, C., Pellitteri, G., Betto, E., Gigli, G. L., Valente, M., Mucchiut, M., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5396705
A molecular atlas of cell-type specific signatures in the parkinsonian striatumPreprint
Graziano, M., Mantas, I., Masarapu, Y., Frapard, S., Garza, R., Adami, A., Fazal, S. V., Quaegebeur, A., Barker, R. A., Jakobsson, J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.09.675138
“Additional evidence comes from multiple system atrophy, a parkinsonism-related disorder characterized by DA neuron loss and α-synuclein accumulation in oligodendrocytes, which results in the formation of glial cytoplasmic inclusions 30 .”
del Rı́o, J. A., Lidón, L., & Gavı́n, R. (2025) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-97055-9_6
Kim, E., Vatsavayai, S. C., & Seeley, W. W. (2025) · Cambridge University Press eBooks · doi:10.1017/9781108985055.004
統一多系統萎縮症評価尺度 UMSARSの邦訳とその信頼性・妥当性
大友, 学., 尾方克久, 鈴木, 幹., 宮武, 聡., 岡橋里美, 望月, 仁., 田村, 拓., & 川井, 充. (2008) · 医療 · doi:10.11261/iryo1946.62.3
痴呆,すくみ足,著明な日内変動,前頭葉萎縮を示す家族性パーキンソン症候群の1家系
龍彦, 湯., 仁, 西., & 英, 吉. (2000) · 医療 · doi:10.11261/iryo1946.54.21
Additional file 2 of Chicago sky blue 6B inhibits α-synuclein aggregation and propagation
Min, J.-O., Strohäker, T., Jeong, B.-C., Zweckstetter, M., & Lee, S.-J. (2022) · Figshare · doi:10.6084/m9.figshare.19445764
Ishimoto, T., Oono, M., Kaji, S., Ayaki, T., Nishida, K., Funakawa, I., Maki, T., Matsuzawa, S.-I., Takahashi, R., & Yamakado, H. (2024) · Figshare · doi:10.6084/m9.figshare.26725517
Corbin-Stein, N. J., Childers, G. M., Webster, J. M., Zane, A., Yang, Y.-T., Mudium, N., Gupta, R., Manfredsson, F. P., Kordower, J. H., & Harms, A. S. (2024) · Figshare · doi:10.6084/m9.figshare.26669316
Hass, E. W., Sorrentino, Z. A., Xia, Y., Lloyd, G. M., Trojanowski, J. Q., Prokop, S., & Giasson, B. I. (2021) · Figshare · doi:10.6084/m9.figshare.16530380
Self-citationIshimoto, T., Oono, M., Kaji, S., Ayaki, T., Nishida, K., Funakawa, I., Maki, T., Matsuzawa, S.-I., Takahashi, R., & Yamakado, H. (2024) · Figshare · doi:10.6084/m9.figshare.26725514
Ishimoto, T., Oono, M., Kaji, S., Ayaki, T., Nishida, K., Funakawa, I., Maki, T., Matsuzawa, S.-I., Takahashi, R., & Yamakado, H. (2024) · Figshare · doi:10.6084/m9.figshare.25902365
Lau, H. H. C., Martínez-Valbuena, I., So, R. W. L., Mehra, S., Silver, N. R. G., Mao, A., Stuart, E., Schmitt-Ulms, C., Hyman, B. T., Ingelsson, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26586450
Ishimoto, T., Oono, M., Kaji, S., Ayaki, T., Nishida, K., Funakawa, I., Maki, T., Matsuzawa, S.-I., Takahashi, R., & Yamakado, H. (2024) · Figshare · doi:10.6084/m9.figshare.26725520
Additional file 1 of Chicago sky blue 6B inhibits α-synuclein aggregation and propagation
Min, J.-O., Strohäker, T., Jeong, B.-C., Zweckstetter, M., & Lee, S.-J. (2022) · Figshare · doi:10.6084/m9.figshare.19445761
Ishimoto, T., Oono, M., Kaji, S., Ayaki, T., Nishida, K., Funakawa, I., Maki, T., Matsuzawa, S.-I., Takahashi, R., & Yamakado, H. (2024) · Figshare · doi:10.6084/m9.figshare.25902428
Sano, T., Nagata, T., Ebihara, S., Yoshida‐Tanaka, K., Nakamura, A., Sasaki, A., Shimozawa, A., Mochizuki, H., Uchihara, T., Hasegawa, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26720163
Marcatori biologici delle malattie neurodegenerative
Vrillon, A., Aveneau, C., & Paquet, C. (2025) · EMC - Neurologia · doi:10.1016/s1634-7072(25)51074-7
Labajová, N., Polak, A., Cehlár, O., Križan, P., Hritz, J., Kolísek, M., Škorvánek, M., Škrabana, R., Kováčech, B., & Žilka, N. (2026) · Molecular Neurobiology · doi:10.1007/s12035-025-05600-2
“In MSA, α-Syn aggregates predominantly form glial cytoplasmic inclusions, also known as Papp–Lantos bodies, which are structures located in the cytoplasm of oligodendrocytes [17, 18].”
Morley, C., Kalef-Ezra, E., Pérez‐Rodríguez, D., Jaunmuktane, Z., & Proukakis, C. (2026) · Acta Neuropathologica · doi:10.1007/s00401-026-03077-4 · Cited by 1
“Although neuronal α-synuclein aggregation is a shared hallmark across all synucleinopa-thies, MSA is uniquely defined by the additional presence of glial cytoplasmic inclusions (GCIs) within oligodendrocytes [13, 66].”
Yildirim-Balatan, C. (2021) · theses.fr (ABES) · doi:10.70675/3372ff2ez69a6z4970z881bze4dfe0a15571
Van, K. T. (2025) · theses.fr (ABES) · doi:10.70675/32a1a6cez5dd3z42c0za2eaz2e57807081a6
The Pharmacology and Dual Role of Proteostasis in Amyloidoses
Albanese, A., Natu, M. M., & Seidler, P. M. (2026) · Biophysica · doi:10.3390/biophysica6020031
Han, Y., & He, Z. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-026-00037-w
RUNX3 negatively regulates autophagic degradation of aggregated α-synucleinPreprint
Tomizawa, I., Chiu, Y., Tatenuma, Y., Hara, N., Hasegawa, M., Kikuchi, M., Mano, T., Ono, M., Morishima, M., Murayama, S., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-9843195/v1
Self-citationStructural biology of alpha-synuclein amyloid filaments: Implications in synucleinopathies
Gonçalves, P. D. C., Fernández, I., & Fernández, C. O. (2026) · Journal of Parkinson s Disease · doi:10.1177/1877718x261461375 · Cited by 1
“In the rod polymorph, the hydrophobic interface between opposing proto fi laments is formed by the preNAC region of the protein ( 46 GGVVHGVTTVA 56 ), which is stabilized by the hydrophobic contacts between the side chains of A53 and V55.”
α-Synuclein suppresses glioma progression through the CDH13–JNK/c-Jun pathway
Yu, Z., Huang, G., Yang, G., Chang, Q., & Zhang, J. (2026) · Journal of Neuro-Oncology · doi:10.1007/s11060-026-05775-1
Kou, X., Hu, Q., Kou, Y., & An, D. (2026) · Frontiers in Toxicology · doi:10.3389/ftox.2026.1814795
“In multiple system atrophy (MSA) (close to 100%), α -syn mainly aggregates within glial cytoplasmic inclusions (GCIs) in oligodendrocytes (Tu et al., 1998).”
Reithofer, S., Sevenich, M. M., Vollmer, M., Kurtul, D., Müller, L. D., Özdüzenciler, P., Gerhards, L., Allmeroth, K., Wendt, M., Charbgoo, F., et al. (2026) · Aggregate · doi:10.1002/agt2.70439
De novo design of flexible protein interactions with GuideFlipPreprint
Yi, K., Chen, Q., Zhang, D., Tian, P., Wagstaff, J. L., McLaughlin, S. H., Tate, C. G., Jamali, K., & Scheres, S. H. W. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.27.754145
“During design, we omitted structural template information for RBX1 residues 1–40, allowing this region to change conformation, and designated residues 28–38 as binding hotspots.”
Price (1999) · doi:10.1002/1531-8249(199903)45:3
Self-citationGoodrum (2000) · doi:10.1002/(sici)1097-4547(20000215)59:4
Self-citationLong term survivors of childhood brain cancer have an increased risk for cardiovascular disease
(2000) · Pure Amsterdam UMC · doi:10.1002/(sici)1097-0142(20000501)88:9
Self-citation- Self-citation
Metadata
- Authors
- Tu, P., Galvin, J. E., Baba, M., Giasson, B., Tomita, T., Leight, S., Nakajo, S., Iwatsubo, T., Trojanowski, J. Q., & Lee, V. M. ‐.
- Affiliations
- University of Pennsylvania (US)
- The University of Tokyo (JP)
- SHOWA Medical University (JP)
- Corresponding author
- Lee, Virginia M.‐Y.
- ORCID
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1998-09
- Volume
- 44
- Issue
- 3
- Pages
- 415-422
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2133068803
- Cited by
- 686
- References
- 43
- Citations by year
- 2026: 14 · 2025: 21 · 2024: 33 · 2023: 23 · 2022: 25 · 2021: 28 · 2020: 21 · 2019: 24 · 2018: 21 · 2017: 23 · 2016: 12 · 2015: 20 · 2014: 24 · 2013: 18 · 2012: 17
- FWCI
- 30.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (MH.NS 31862)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- alpha-synuclein, glial cytoplasmic inclusions, multiple system atrophy, oligodendrocytes, white matter, Lewy bodies, protein aggregation, neurodegenerative movement disorders, immunoelectron microscopy, synuclein
- MeSH terms
- Adult, Aged, Aged, 80 and over, Antibodies, Inclusion Bodies, Female, Humans, Male, Actin Cytoskeleton, Middle Aged, Myelin Sheath, Nerve Tissue Proteins, Neuroglia, Oligodendroglia, Solubility, Multiple System Atrophy, Synucleins, alpha-Synuclein, gamma-Synuclein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
